☆ 4.4 Article

Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study

Expert Review of Gastroenterology & Hepatology (2015)

Journal

Expert Review of Gastroenterology & Hepatology

Volume 9, Issue sup1, Pages 45-52

Publisher

Informa UK Limited

DOI: 10.1586/17474124.2015.1091308

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.